Evidence map›Paper›PMID 29980617›Full record

ArticleScience immunology2018

Metabolic signaling directs the reciprocal lineage decisions of αβ and γδ T cells.

Kai Yang, Daniel Bastardo Blanco, Xiang Chen, Pradyot Dash, Geoffrey Neale, Celeste Rosencrance, John Easton, Wenan Chen, Changde Cheng, Yogesh Dhungana and 5 more

Abstract read
In one paragraph

Article in Science immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Review
  2. Article
  3. Metabolic control of innate-like T cells.Nature reviews. Immunology · 2026
    Review
  4. Review
  5. Food for thought: Nutrient metabolism controlling early T cell development.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kai YangDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. hongbo.chi@stjude.org.ORCID 0000-0003-3103-5719
Daniel Bastardo BlancoDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0001-8232-7522
Xiang ChenDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-2499-8261
Pradyot DashDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0001-5467-0657
Geoffrey NealeHartwell Center for Bioinformatics and Biotechnology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0003-3776-0858
Celeste RosencranceDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0001-7898-233X
John EastonDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0003-4503-6608
Wenan ChenDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0003-0379-2368
Changde ChengDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-2458-2522
Yogesh DhunganaDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Anil KcDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Walid AwadDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Xi-Zhi J GuoDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-5564-3287
Paul G ThomasDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0001-7955-0256
Hongbo ChiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. hongbo.chi@stjude.org.ORCID 0000-0002-9997-2496

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Regulation of TH17 plasticity and stemness by mTORC1R01AI131703 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Hongbo Chi · 2018 to 2026
$4.1M
The MKP-1/p38 axis: coordinating innate and adaptive immunityR01NS064599 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2008 to 2018
$3.7M
Metabolic checkpoint in dendritic cell subsets and adaptive immunityR37AI105887 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Hongbo Chi · 2019 to 2026
$3.6M
Mechanisms to diversify repertoire and modify T cell activity after infectionR01AI107625 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI THOMAS, PAUL G. · 2013 to 2017
$2.3M
A protective role for gamma delta T cells in respiratory infectionR01AI121832 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI THOMAS, PAUL G. · 2016 to 2020
$2.2M
Metabolic checkpoint in TH17 cell differentiationR01AI105887 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2014 to 2018
$2.2M
mTOR signaling in T cell quiescenceR01AI101407 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2013 to 2017
$2.2M
Tsc1/mTOR axis in immune homeostasis and tumorigenesisR01CA176624 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2014 to 2018
$1.9M
Metabolic reprogramming of Tregs in tumor immunityR01CA221290 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2017 to 2020
$1.6M
NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA176624NCI NIH HHS R01 CA221290NIAID NIH HHS R01 AI101407NIAID NIH HHS R01 AI105887NIAID NIH HHS R01 AI107625NIAID NIH HHS R01 AI121832NIAID NIH HHS R01 AI131703NIAID NIH HHS R37 AI105887NINDS NIH HHS R01 NS064599
6 · The paper itself

Abstract

The interaction between extrinsic factors and intrinsic signal strength governs thymocyte development, but the mechanisms linking them remain elusive. We report that mechanistic target of rapamycin complex 1 (mTORC1) couples microenvironmental cues with metabolic programs to orchestrate the reciprocal development of two fundamentally distinct T cell lineages, the αβ and γδ T cells. Developing thymocytes dynamically engage metabolic programs including glycolysis and oxidative phosphorylation, as well as mTORC1 signaling. Loss of RAPTOR-mediated mTORC1 activity impairs the development of αβ T cells but promotes γδ T cell generation, associated with disrupted metabolic remodeling of oxidative and glycolytic metabolism. Mechanistically, we identify mTORC1-dependent control of reactive oxygen species production as a key metabolic signal in mediating αβ and γδ T cell development, and perturbation of redox homeostasis impinges upon thymocyte fate decisions and mTORC1-associated phenotypes. Furthermore, single-cell RNA sequencing and genetic dissection reveal that mTORC1 links developmental signals from T cell receptors and NOTCH to coordinate metabolic activity and signal strength. Our results establish mTORC1-driven metabolic signaling as a decisive factor for reciprocal αβ and γδ T cell development and provide insight into metabolic control of cell signaling and fate decisions.

Indexed as

AnimalsCell DifferentiationCell LineageMechanistic Target of Rapamycin Complex 1Mice, Inbred C57BLMice, TransgenicProto-Oncogene Proteins c-mycReactive Oxygen SpeciesRegulatory-Associated Protein of mTORSignal TransductionThymus GlandT-Lymphocyte SubsetsMechanistic Target of Rapamycin Complex 1Myc protein, mouseProto-Oncogene Proteins c-mycReactive Oxygen SpeciesRegulatory-Associated Protein of mTORRptor protein, mouse

Identifiers

PMID29980617
PMCPMC6230375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.